ArticleAnnals of medicine2026
Clinical predictors for bloodstream infection in systemic lupus erythematosus.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to investigate the distribution of pathogenic bacteria and identify clinical predictors associated with bloodstream infection (BSI) in patients with systemic lupus erythematosus (SLE).
methodsThe experimental group included 43 SLE patients with BSI (SLE-BSI), who were diagnosed and treated at the First Affiliated Hospital of Sun Yat-sen University between October 2013 and June 2023. The control group consisted of 172 SLE patients without BSI (SLE-non-BSI), randomly selected at a 1:4 ratio and matched for age, gender, and ward with the case group. Logistic regression analyses of clinical data and laboratory indicators were used to identify independent clinical predictors for SLE-BSI.
resultsThe most common pathogens identified in SLE-BSI patients were
conclusionFor SLE patients receiving glucocorticoid therapy, the presence of myalgia and fever should raise suspicion of BSI. The findings may help optimize the clinical utility of blood culture testing, thereby facilitating the early identification of BSI in SLE patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.